BPC-157
BPC-157
Multi-buy savings: save 4% on 2+ items and 6% on 3+. Applied automatically in your cart.
Couldn't load pickup availability
- Same-day dispatch on orders before 2pm, Royal Mail Tracked
- Free UK shipping on orders over £100
- Certificate of Analysis with every order · View CoA
- Independent test: Janoshik Analytical, March 2026 · View report
- For in vitro laboratory research use only
Concentration calculator
For laboratory calculation only. Not for human or veterinary use.
BPC-157 (Body Protection Compound-157; sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) is a synthetic pentadecapeptide derived from a body protection compound found in human gastric juice. It is one of the most widely published peptides in preclinical literature, studied in models of angiogenesis, connective-tissue biology and gastrointestinal mucosa.
BPC-157 has been shown in preclinical models to modulate VEGF, EGF, and nitric oxide signalling pathways, while also influencing dopaminergic and serotonergic neurotransmission. Its exceptional stability in human gastric juice and broad preclinical activity profile make it one of the most studied compounds in angiogenesis and GI research.
Specifications
| CAS | 137525-51-0 |
|---|---|
| Formula | C62H98N16O22 |
| MW | 1419.5 g/mol |
| Purity | ≥99% HPLC |
| Format | Lyophilised powder |
| Storage | −20 °C |
Research areas
- Angiogenesis
- GI mucosal biology
- Tendon & ligament models
- Cell migration
- Nitric oxide signalling
- Neurological models
Selected literature
Research Use Only. Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.
Share
